検索結果 - Norbert Gattermann

結果の絞り込み
  1. 1
    Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

    Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload 著者: Norbert Gattermann

    出版事項 2008
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    The Treatment of Secondary Hemochromatosis

    The Treatment of Secondary Hemochromatosis 著者: Norbert Gattermann

    出版事項 2009
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  3. 3
    Iron overload in myelodysplastic syndromes (MDS)

    Iron overload in myelodysplastic syndromes (MDS) 著者: Norbert Gattermann

    出版事項 2017
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  4. 4
    Valproic acid for the treatment of myeloid malignancies

    Valproic acid for the treatment of myeloid malignancies 著者: Andrea Kuendgen, Norbert Gattermann

    出版事項 2007
    全文の入手 全文の入手
    Carta
    お気に入りに追加
    保存先:
  5. 5
    Iron overload in MDS—pathophysiology, diagnosis, and complications

    Iron overload in MDS—pathophysiology, diagnosis, and complications 著者: Norbert Gattermann, Eliezer A. Rachmilewitz

    出版事項 2010
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  6. 6
    Myelodysplastic Syndromes

    Myelodysplastic Syndromes 著者: Peter L. Greenberg, Neal S. Young, Norbert Gattermann

    出版事項 2002
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  7. 7
    Myelodysplastic Syndromes

    Myelodysplastic Syndromes 著者: Ulrich Germing, Guido Kobbe, Rainer Haas, Norbert Gattermann

    出版事項 2013
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  8. 8
    The evaluation of iron deficiency and iron overload

    The evaluation of iron deficiency and iron overload 著者: Norbert Gattermann, Martina U. Muckenthaler, Andreas E. Kulozik, Georgia Metzgeroth, Jan Hastka

    出版事項 2021
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  9. 9
    Myelodysplastic Syndromes in Patients Younger Than Age 50

    Myelodysplastic Syndromes in Patients Younger Than Age 50 著者: Andrea Kuendgen, Corinna Strupp, Manuel Aivado, Barbara Hildebrandt, Rainer Haas, Norbert Gattermann, Ulrich Germing

    出版事項 2006
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients With Acquired Idiopathic Sideroblastic Anemia

    Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients With Acquired Idiopathic Sideroblastic Anemia 著者: Norbert Gattermann, Stefan Retzlaff, Yanling Wang, Götz Hofhaus, Jürgen J. Heinisch, Carlo Aul, Wolfgang Schneider

    出版事項 1997
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

    High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifia... 著者: Norbert Gattermann, Johan Billiet, Ralf Kronenwett, E. Zipperer, Ulrich Germing, Friedel Nollet, A. Criel, Dominik Selleslag

    出版事項 2007
    全文の入手 全文の入手
    Carta
    お気に入りに追加
    保存先:
  12. 12
    Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

    Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid 著者: Andrea Kuendgen, Corinna Strupp, Manuel Aivado, A. Bernhardt, Barbara Hildebrandt, Rainer Haas, Ulrich Germing, Norbert Gattermann

    出版事項 2004
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

    The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome 著者: E. Zipperer, D. Pelz, Kathrin Nachtkamp, A. Kuendgen, C. Strupp, Norbert Gattermann, Rainer Haas, Ulrich Germing

    出版事項 2009
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes

    Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes 著者: Sabine Knipp, Barbara Hildebrand, Andrea Kündgen, Aristoteles Giagounidis, Guido Kobbe, Rainer Haas, Carlo Aul, Norbert Gattermann, Ulrich Germing

    出版事項 2007
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes

    Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes 著者: Judith Neukirchen, Sabine Blum, Andrea Kuendgen, Corinna Strupp, Manuel Aivado, Rainer Haas, Carlo Aul, Norbert Gattermann, Ulrich Germing

    出版事項 2009
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Chronic myelomonocytic leukemia in the light of the WHO proposals

    Chronic myelomonocytic leukemia in the light of the WHO proposals 著者: Ulrich Germing, C. Strupp, S. Knipp, A. Kuendgen, Aristoteles Giagounidis, B. Hildebrandt, C. Aul, R Haas, Norbert Gattermann, John M. Bennett

    出版事項 2007
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia

    The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia 著者: Andrea Kuendgen, Mathias Schmid, Richard F. Schlenk, Sabine Knipp, Barbara Hildebrandt, Christian Steidl, Ulrich Germing, Rainer Haas, Hartmut Döhner, Norbert Gattermann

    出版事項 2005
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes

    Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes 著者: Lewis R. Silverman, Pierre Fenaux, Ghulam J. Mufti, Valeria Santini, Eva Hellström‐Lindberg, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells

    Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells 著者: Ulrich Steidl, Ralf Kronenwett, Ulrich‐Peter Rohr, Roland Fenk, Slawomir Kliszewski, Christian Maercker, Peter Neubert, Manuel Aivado, J. H. Koch, Olga Modlich, Hans Bojar, Norbert Gattermann, Rainer Haas

    出版事項 2002
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients

    High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients 著者: Jeffrey W. Tyner, Heidi S. Erickson, Michael W. Deininger, Stephanie G. Willis, Christopher A. Eide, Ross L. Levine, Michael C. Heinrich, Norbert Gattermann, D. Gary Gilliland, Brian J. Druker, Marc Loriaux

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: